Shubh Sinha’s Post

View profile for Shubh Sinha, graphic

CEO at Integral | Maximizing the leverage of regulated data

Across the countless conversations I’ve had with data leaders in pharma, these same challenges keep popping up again and again: 1. Data Fragmentation - Managing 10+ data sources is becoming necessary to understand the consumer at scale. Across teams, building a compliant, rich "single source of truth" is a significant challenge. 2. Regulatory Evolution - With traditional approaches, keeping up with new data and AI regulations is becoming a full-time job. Governance frameworks need to evolve quickly. This isn't just about checking boxes anymore - it's about building iteratively. 3. The AI Balance - AI capabilities are in high demand, but privacy considerations take precedence before the technology can be fully utilized. Your data scientists need agility, your privacy team demands security, and you're stuck navigating the balance. Traditional de-identification methods can't keep up with the pace of innovation. 4. Time-to-Value Challenges - Companies invest heavily in data acquisition, but lose momentum during the data deployment processes due to compliance. When your data compliance reviews take 12+ weeks, but your dev cycle is 2 weeks, something needs to change. 5. Partner Ecosystem Growth - The reality of modern pharma: you're probably working with 15+ data partners, each with their own standards and requirements. Integration isn't just technical - it's about aligning compliance across your entire ecosystem. What I'm Seeing Work: The companies who are moving quickly are taking an enterprise-wide strategy to intertwine data and compliance by: ✔️ Implementing automated privacy tools (but choosing them carefully) ✔️ Building flexible governance frameworks that can adapt quickly ✔️ Investing in solutions like Integral Privacy Technologies’s Continuous Monitoring instead of traditional consulting What challenges are you seeing in your organization? Would love to hear your thoughts. #PharmaData #Privacy P.S. If you’re facing these challenges please contact us and we can discuss how our learnings can be tailored to your data strategy

To view or add a comment, sign in

Explore topics